RCKT
Price
$6.60
Change
-$0.25 (-3.65%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
709.99M
82 days until earnings call
REPL
Price
$8.44
Change
-$0.75 (-8.16%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
651.55M
One day until earnings call
Interact to see
Advertisement

RCKT vs REPL

Header iconRCKT vs REPL Comparison
Open Charts RCKT vs REPLBanner chart's image
Rocket Pharmaceuticals
Price$6.60
Change-$0.25 (-3.65%)
Volume$60.24K
Capitalization709.99M
Replimune Group
Price$8.44
Change-$0.75 (-8.16%)
Volume$53.39K
Capitalization651.55M
RCKT vs REPL Comparison Chart
Loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. REPL commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and REPL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (RCKT: $6.85 vs. REPL: $9.19)
Brand notoriety: RCKT and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 77% vs. REPL: 203%
Market capitalization -- RCKT: $738M vs. REPL: $651.55M
RCKT [@Biotechnology] is valued at $738M. REPL’s [@Biotechnology] market capitalization is $651.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $292.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, both RCKT and REPL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 4 TA indicator(s) are bullish while REPL’s TA Score has 8 bullish TA indicator(s).

  • RCKT’s TA Score: 4 bullish, 4 bearish.
  • REPL’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, REPL is a better buy in the short-term than RCKT.

Price Growth

RCKT (@Biotechnology) experienced а +3.55% price change this week, while REPL (@Biotechnology) price change was +24.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.03%. For the same industry, the average monthly price growth was +10.44%, and the average quarterly price growth was -1.84%.

Reported Earning Dates

RCKT is expected to report earnings on Aug 11, 2025.

REPL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($710M) has a higher market cap than REPL($652M). REPL YTD gains are higher at: -30.140 vs. RCKT (-47.574). REPL has higher annual earnings (EBITDA): -216.51M vs. RCKT (-246.03M). REPL has more cash in the bank: 537M vs. RCKT (318M). RCKT has less debt than REPL: RCKT (25.4M) vs REPL (76M). RCKT (0) and REPL (0) have equivalent revenues.
RCKTREPLRCKT / REPL
Capitalization710M652M109%
EBITDA-246.03M-216.51M114%
Gain YTD-47.574-30.140158%
P/E RatioN/AN/A-
Revenue00-
Total Cash318M537M59%
Total Debt25.4M76M33%
FUNDAMENTALS RATINGS
RCKT vs REPL: Fundamental Ratings
RCKT
REPL
OUTLOOK RATING
1..100
6616
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
6563
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REPL's Valuation (25) in the Biotechnology industry is in the same range as RCKT (28). This means that REPL’s stock grew similarly to RCKT’s over the last 12 months.

REPL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that REPL’s stock grew similarly to RCKT’s over the last 12 months.

RCKT's SMR Rating (94) in the Biotechnology industry is in the same range as REPL (95). This means that RCKT’s stock grew similarly to REPL’s over the last 12 months.

REPL's Price Growth Rating (63) in the Biotechnology industry is in the same range as RCKT (65). This means that REPL’s stock grew similarly to RCKT’s over the last 12 months.

REPL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that REPL’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTREPL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VOLMX23.34N/A
N/A
Volumetric
MLPEX7.60N/A
N/A
Invesco SteelPath MLP Select 40 C
EGLIX10.44N/A
N/A
Eagle Energy Infrastructure I
TIRRX11.58N/A
N/A
T. Rowe Price Real Estate I
FIADX54.64N/A
N/A
Fidelity Advisor International Discv I

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-3.80%
NTLA - RCKT
61%
Loosely correlated
-4.86%
XNCR - RCKT
60%
Loosely correlated
-7.62%
ACLX - RCKT
59%
Loosely correlated
+8.26%
RGNX - RCKT
58%
Loosely correlated
-3.60%
KYMR - RCKT
58%
Loosely correlated
-4.17%
More

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with ELVAF. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-7.94%
ELVAF - REPL
60%
Loosely correlated
N/A
RCKT - REPL
51%
Loosely correlated
-3.80%
SNDX - REPL
47%
Loosely correlated
+0.76%
IDYA - REPL
44%
Loosely correlated
-2.45%
KYMR - REPL
44%
Loosely correlated
-4.17%
More